Peripheral Vascular Devices Market Development Factors and Investment Analysis by Leading Manufacturers
The global peripheral vascular devices market size is projected to reach USD 13.4 billion by 2026 from USD 10.3 billion in 2021, at a CAGR of 5.3% from 2021 to 2026. The growth of this market is driven by rapid growth in the geriatric population and the subsequent increase in the prevalence of peripheral vascular diseases, favorable reimbursement scenario for peripheral vascular procedures, Increased number of product approvals, increased prevalence of diabetes, and rising rate of tobacco consumption.
Request for Sample PDF Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=790
Peripheral vascular devices and equipment are used to treat peripheral vascular diseases which are slow and progressive blood circulation disorders caused by blockages, narrowing, or spasms in blood vessels outside the heart and brain including arteries and veins.
The study involved four major activities in estimating the current size of the peripheral vascular devices market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.
Key Market Players
The major players in the peripheral vascular devices market Medtronic (Ireland), Boston Scientific Corporation (US), Abbott (US), Becton, Dickinson and Company (US), Terumo Corporation (Japan), Cardinal Health (US), B. Braun Melsungen AG (US), Merit Medical Systems (US), Penumbra, Inc.(US), Koninklijke Philips N.V.( Netherlands), iVascular S.L.U (Spain), Biosensors International Group Ltd. (Singapore), BIOTRONIK (Germany), AMG International GmbH (US), ENDOCOR GmbH (Germany).
North America dominates the global peripheral vascular devices market.
The peripheral vascular devices market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World. North America accounted for the largest share of the peripheral vascular devices market. The large share of North America can be attributed to the growth in the geriatric population and the high prevalence of peripheral vascular diseases.
Browse Complete insights along with TOC @ https://www.marketsandmarkets.com/Market-Reports/interventional-cardiology-peripheral-vascular-devices-market-790.html
This research report categorizes the peripheral vascular devices market into the following segments and sub-segments:
By Product
- Angioplasty Balloons
- Angioplasty Stents
- Catheters
- Endovascular Aneurysm Repair Stent Grafts
- Inferior Vena Cava Filters
- Plaque Modification Devices
- Hemodynamic Flow Alteration Device Market
- Other Peripheral Vascular Devices
By Region
- North America
- Europe
- Asia Pacific
- Rest of the World
Recent Developments:
- Medtronic received the US FDA approval for its IN. PACT AV drug-coated balloon (DCB) to treat arteriovenous fistula lesions
- Boston Scientific Corporation received the FDA Approval for its VICI VENOUS STENT System for treating patients with deep venous blockages.
Inquire for a Discount on this Premium Report @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=790
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
English
Arabic
Français
Español
Português
Deutsch
Dutch
Italiano
Russian
Romaian